![Michael Schaefer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Michael Schaefer is currently the Director at 2cureX ApS since 2022.
Prior to this, he was the Co-Managing Director at Sysmex Europe SE and the Executive Vice President at Sysmex Corp.
He also served as an Independent Director at 2cureX AB from 2022 to 2024.
Posizioni attive di Michael Schaefer
Società | Posizione | Inizio |
---|---|---|
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Direttore/Membro del Consiglio | 01/01/2022 |
Precedenti posizioni note di Michael Schaefer
Società | Posizione | Fine |
---|---|---|
2CUREX AB | Direttore/Membro del Consiglio | 04/01/2024 |
SYSMEX CORPORATION | Corporate Officer/Principal | - |
Sysmex Europe SE
![]() Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
SYSMEX CORPORATION | Health Technology |
2CUREX AB | Health Technology |
Aziende private | 2 |
---|---|
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
Sysmex Europe SE
![]() Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Health Technology |
- Borsa valori
- Insiders
- Michael Schaefer